FDA Determines Regulatory Review Period for ONSIOR Patent Extension

Summary

The FDA has published a notice determining the regulatory review period for ONSIOR, an animal drug product, in response to patent extension applications submitted to the Director of Patents and Trademarks at the Department of Commerce.